{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:40:51Z","timestamp":1777887651753,"version":"3.51.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interstitial fibrosis and tubular atrophy (IFTA) are key pathological features of chronic kidney damage and progression in diabetic nephropathy (DN). Early identification of patients at higher risk of IFTA may support risk stratification, although reliable non-invasive tools remain limited. This study aimed to develop and validate machine learning (ML) models for predicting IFTA in patients with biopsy-confirmed DN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective study, 232 patients with biopsy-confirmed DN from 2017 to 2025 were included and randomly divided into a training cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0164) and a validation cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a068). Baseline clinical and laboratory variables were collected. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation. Seven ML algorithms\u2014logistic regression, support vector machine, random forest, XGBoost, LightGBM, decision tree, and artificial neural network\u2014were developed. Model performance was evaluated using receiver operating characteristic curves, calibration plots, and decision curve analysis. Model interpretability was assessed using SHAP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven predictors were identified, including diabetic retinopathy, age, proteinuria, estimated glomerular filtration rate (eGFR), triglycerides, duration of diabetes, and hemoglobin. Among the models, XGBoost achieved the highest AUC in the validation cohort, with an area under the curve (AUC) of 0.759, accuracy of 72.1%, sensitivity of 92.3%, specificity of 44.8%, and F1 score of 79.1%. Overall, the model showed moderate discrimination, with high sensitivity but limited specificity, suggesting potential value for exploratory risk screening rather than definitive clinical use. SHAP analysis indicated that higher proteinuria, triglycerides, presence of diabetic retinopathy, and longer diabetes duration, together with lower eGFR, hemoglobin, and younger age, were associated with an increased predicted risk of IFTA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ML models, particularly XGBoost, showed moderate performance in predicting IFTA in patients with biopsy-confirmed DN using routinely available clinical variables. These findings support the feasibility of an interpretable, non-invasive approach for exploratory risk estimation of tubulointerstitial injury. However, because of the modest sample size, limited specificity, relatively high false positive rate, and lack of external validation, the present results should be considered preliminary and require further validation before clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1852512","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:20:01Z","timestamp":1777609201000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of an explainable machine learning model for predicting interstitial fibrosis and tubular atrophy in biopsy-confirmed diabetic nephropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Huifang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mdb2.70020","article-title":"Towards comprehensive chronic disease control: prevention, early detection, and integrated management","volume":"2","author":"Sun","year":"2026","journal-title":"Med Bull"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.26599\/FMH.2026.9420115","article-title":"Medicine food homology\u201d plants in the treatment of diabetic nephropathy: pathogenic pathways and therapeutic approaches","volume":"3","author":"Yan","year":"2026","journal-title":"Food Med Homol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0524-0","article-title":"Mechanisms of progression of chronic kidney disease","volume":"22","author":"Fogo","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA consensus conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/med4.83","article-title":"Clinical decision making: evolving from the hypothetico\u2010deductive model to knowledge\u2010enhanced machine learning","volume":"2","author":"Yuan","year":"2024","journal-title":"Med Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/8857453","article-title":"Explainable machine learning-based prediction model for diabetic nephropathy","volume":"2024","author":"Yin","year":"2024","journal-title":"J Diabetes Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8637138","article-title":"Classification and differential diagnosis of diabetic nephropathy","volume":"2017","author":"Qi","year":"2017","journal-title":"J Diabetes Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/g3journal\/jkab032","article-title":"Heuristic hyperparameter optimization of deep learning models for genomic prediction","volume":"11","author":"Han","year":"2021","journal-title":"G3 (Bethesda)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1037\/met0000563","article-title":"Missing data: an update on the state of the art","volume":"30","author":"Enders","year":"2025","journal-title":"Psychol Methods"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.12.002","article-title":"Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: a single-center study in China","volume":"30","author":"Zhu","year":"2016","journal-title":"J Diabetes Complic"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016333","article-title":"Histologic predictors of renal outcome in diabetic nephropathy: beyond renal pathology society classification","volume":"98","author":"Stefan","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"22023","DOI":"10.1038\/s41598-020-79146-9","article-title":"Reduced lifespan of erythrocytes in Dahl\/Salt sensitive rats is the cause of the renal proximal tubule damage","volume":"10","author":"Manabe","year":"2020","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0650-7","article-title":"Updating the natural history of diabetic nephropathy","volume":"51","author":"Pugliese","year":"2014","journal-title":"Acta Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2644681","article-title":"Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1852512\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:20:01Z","timestamp":1777609201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1852512\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":19,"alternative-id":["10.3389\/fendo.2026.1852512"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1852512","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"1852512"}}